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Abstract 
Background 
Congenital heart disease (CHD) is the most common birth defect and affects almost 1% 
of all live births.  Treatment anxiety is common among children with CHD who undergo 
multiple procedures early in their lifetime.  Dramatically increased life spans for this cardiac 
population has led to a shift from focusing on survival to their long-term health outcomes.  
Methods: 
 Administration of the Peds QL Cardiac Module 3.0 assesses health related quality of life 
(HRQOL) during annual visits to a Cardiac Neurodevelopmental (ND) Clinic by evaluating the 
level of Treatment Anxiety a patient experiences during healthcare appointments.  The 
questionnaire scores are inversely rated, with higher scores correlating to less Treatment 
Anxiety.  Patients and parents/guardians received targeted education on treatment anxiety, its 
causes, coping tools, and resources.  Pre/post measures of treatment anxiety were measured. 
Findings:  
There were 7 children aged 5-17 years old enrolled over a period of three months. All but 
one had measurably decreased treatment anxiety after the intervention. Almost every parent 
endorsed feelings of being heard and gratitude for the education intervention as well. 
Discussion:   
This project is a simple, yet effective demonstration that proper education can positively 
influence pediatric patient outcomes. Focusing on mental health and long-term outcomes for 
patients with CHD is important and achievable during annual ND appointments. 
Application to Practice:  
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Implementing age-appropriate education on treatment anxiety and coping mechanisms 
during ND visits is feasible and cost-saving, improving improves short- and long-term outcomes 
for mental health in congenital cardiac patients.  More research is needed for longer term 
outcomes with these interventions. 
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EBP Project: Treatment anxiety education for pediatric Cardiac 
Neurodevelopmental patients 
Clinical Problem 
 Congenital heart disease (CHD) is the most common birth defect, affecting almost 
1% of all live births (Kaugers et al., 2017).  In the United States alone, over 35,000 infants are 
born annually with CHD, and more than a third of these infants have complex CHD (Wernovsky 
et al., 2018).  There are a wide range of defects and severity; many children are subject to 
lifelong treatment and monitoring, which can include surgical intervention in infancy.  
Fortunately, over the past few decades, mortality in this population has significantly improved, 
yet not all health outcomes have had such progress (Wilmot et al., 2015).  There are currently 
over one million adults living in the US with many types of CHDs, with an estimated 150,000 
adults with complex CHD (Wernovsky et al., 2018).   
This increased survival rate and life expectancy has resulted in identification of new 
comorbidities for this patient population, including mental health disorders and 
neurodevelopmental delays (Uzark et al., 2008; Wilmot et al., 2015).  There are many factors 
that impact the presence of anxiety, depression, and ADHD in addition to neurodevelopmental 
delays (NDDs) for children and adolescents through adulthood with CHD.  Some of these risk 
factors include the presence of underlying genetic syndromes, previous surgeries, familial mental 
health disorders, time on cardiopulmonary bypass, prematurity, and prolonged hospitalization 
(Gonzalez et al., 2021).  According to Gonzalez et al. (2021), 50-75% of children with complex 
CHD, such as single ventricle physiology, deal with NDDs and a subsequent reduction in quality 
of life.  These mental health comorbidities and developmental issues can lead to significant 
lifelong problems for this cardiac population. 
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Problem Clarification 
The general population of 2 to 11-year-olds have a national prevalence of anxiety and 
depression of 3 and 7% respectively (Gonzalez et al., 2021).  In contrast, patients with CHD 
were found to have a much higher prevalence (16%) of anxiety and/or depression diagnosis 
(Gonzalez et al., 2021).  Adolescents with CHD have more than double the likelihood of anxiety 
and/or depression when compared with other adolescents without CHD (Gonzalez et al., 2021).  
Anxiety prevalence is important because the presence of anxiety is directly related to reduced 
Pediatric Cardiac Quality of Life Inventory scores (Marino et al., 2012).   
Treatment anxiety or procedural anxiety is common among pediatric patients and 
especially for children with special health care needs like CHD who have experienced multiple 
surgeries or procedures (Goldman-Luthy, 2019).  Treatment anxiety can be defined as “the fear 
or worry related to any medical procedure that can interfere with your ability to receive 
appropriate medical care” (“Procedural anxiety,” n.d.).  Procedural anxiety stems from fear of 
pain, which may be perceived or real, or from the memory of previous negative experiences 
(Goldman-Luthy, 2019).  The scope of procedures that induce anxiety can greatly vary, anything 
from a routine diaper change to invasive interventional procedures (Goldman-Luthy, 2019).  This 
matter is important because it affects not only the patient but the whole family unit. 
Substantial progress in medical and surgical care has drastically extended the life 
expectancy for children born with CHD; now almost 90% of children with CHD end up 
surviving to adulthood (Uzark et al., 2008).  With these exciting advances, the focus of care 
needs to shift beyond just survival and to long term health outcomes in this developing 
population.  Quality of Life and health related measures have become the emphasis for 
healthcare promotion in cardiac patients (Uzark et al., 2008).  Pediatric mental health has also 
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been highlighted greatly recently, in the context of the past few years and as a result of the 
Covid-19 pandemic.  According to the American Heart Association, “periodic developmental 
surveillance, screening, evaluation, and reevaluation throughout childhood may enhance 
identification of significant deficits, allowing for appropriate therapies and education to enhance 
later academic, behavioral, psychosocial, and adaptive functioning” (Marino et al., 2012, p. 
1143).   
Utilizing specific management protocols, such as family education or proper referrals, 
can improve the efficacy of Health-related quality of life (HRQOL) surveillance and better 
patient health (Varni et al., 2005).  The PedsQL 3.0 Cardiac Module consists of a 27-item 
questionnaire that has 6 themes: Heart problems and treatment, Treatment II, Perceived physical 
appearance, treatment anxiety, cognitive problems, and communication.  This project’s focus 
was the Treatment Anxiety questionnaire and subsequent scores which consisted of 4 questions 
rated on a 5-point Likert scale.  These scores are inversely rated, with higher scores correlating to 
less Treatment Anxiety.  This survey is a HRQOL measuring tool and suited to this pediatric 
cardiac population. 
Summary of Evidence 
In searching for evidence related to the treatment anxiety and HRQOL measures, clinical 
databases such as CINAHL, Cochrane, and PubMed were utilized.  Keywords such as “treatment 
anxiety”, “Health Related Quality of Life”, “pediatric”, and “congenital heart disease” were used 
in the search.  In total, 13 articles were selected and reviewed, including clinical practice 
guidelines, cross sectional surveys and prospective studies.  Two articles described treatment 
anxiety, its prevalence in children, and its implications for receiving medical care.  Four of the 
articles recognized the significance of the clinical problem in addition to identifying current gaps 
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in the literature.  Another two studies discussed outcomes related to pediatric mental health, and 
a third detailed the annual costs of anxiety and depression in children with special health needs.   
A comparative cross-sectional study of over 1100 patients found that a significant 
number of youth with CHD have higher rates of mental health disorders and that screening this 
population for anxiety and depression disorders is indicated (Gonzalez et al., 2021).  Two studies 
found the Peds QL Cardiac Module 3.0 to be feasible, reliable, and valid in assessing HRQOL in 
pediatric patients with CHD (Uzark et al., 2003; Varni et al., 2005).  According to Uzark et al. 
(2008), children with CHD report lower quality of life than healthy children in all age groups. 
Strengths and Limitations: 
In reviewing the current literature for management of treatment anxiety, there are both 
strengths and limitations present.  In recent decades, growing attention has turned to the mental 
health crisis in youth, with much more time and research devoted.  Due to the burden associated 
with anxiety and depression and their added morbidity throughout life, managing mental health 
has become an increasing priority in primary care (Pella et al., 2020).  The existing depth and 
breadth of research on the impact of anxiety and depression on HRQOL, costs, and solutions is 
substantial.  This evidence is wide-ranging and integral to creating this EBP project on treatment 
anxiety.     
Unfortunately, there are also limitations associated with the research on  
mental health illness and HRQOL indicators.  There is no meta-analysis or systematic review 
included in my literature review of this subject.  The lack of a comprehensive article such as a 
systematic review suggests that there is a solid foundation of research for this clinical problem, 
but there is insufficient data and evidence thus far on interventions and clinical outcomes for 
mental health disorders in this specific population.  Multiple articles also cite limitations due to 
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small populations and lack of diversity in their participants (Kaugers et al., 2017; Pella et al., 
2020; Uzark et al., 2008).  Many of the studies only focused on patients with one or two specific 
cardiac defects such as single ventricle physiology; in reality, there is a wide range of CHDs that 
affect this cardiac population (Gonzalez et al., 2021; Kaugers et al., 2017).  Research in the 
future should focus on youth of all backgrounds, income classes, and with a range of cardiac 
defects.  
Evidence Based Intervention 
This project focused on screening for treatment anxiety in pediatric patients with cardiac 
defects being seen at the Cardiac Neurodevelopmental Clinic of a large, regional, pediatric 
referral hospital.  The purpose of this outpatient clinic is to evaluate the growth and development 
of infants and young children with congenital heart disease.  Risk reduction through early 
identification and treatment of multisystem problems is important for successful development 
and improved quality of life.  Since quality of life cannot be exactly gathered from clinical or 
laboratory results, optimizing health related interventions and outcomes depends on proven 
measures for evaluating quality of life (Uzark et al., 2003).  The literature, as previously stated, 
supports the validity and reliability of the Peds QL Cardiac Module 3.0 for this patient 
population.  This is a valid and reliable measuring tool for HRQOL in this population. 
The capability of an instrument to impact both clinical practice and patient outcomes 
derives from the measuring tool’s effect on clinical decisions (Uzark et al., 2003).  Screening this 
group of patients for treatment anxiety is one of the evidence-based interventions in this project.  
Regardless of the treatment anxiety score, all patients and families were given an informative 
handout and educated on treatment anxiety background, coping mechanisms, and symptoms 
during a detailed discussion.  The patient education is the project’s second and more significant 
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intervention.  The primary outcome from this project is the treatment anxiety score from the Peds 
QL Module; the project’s overall objective is to improve these scores after a short, uniform 
education piece. 
Gap Analysis 
This Cardiac Neurodevelopmental Clinic was started in February 2020 as a transition for 
patients from the High Risk Infant Follow-up Clinic.  The focus of this new clinic is to evaluate 
and monitor the neurodevelopmental outcomes of cardiac patients annually from childhood 
through adolescence.  The Peds QL Cardiac Module 3.0 was already being administered during 
these appointments prior to this DNP Project.  A considerable gap was present, due to the 
novelty of this clinic.  An experienced Nurse Practitioner identified an opportunity for this EBP 
Project regarding treatment anxiety.  On the Peds QL assessment, the treatment anxiety section 
regularly scored low for these patients.  Additionally, parents were voicing concerns over patient 
anxiety during medical procedures and regular appointments.  This project capitalizes on the 
intersection of the movements towards neurodevelopmental outcomes in cardiac patients, mental 
health, and patient centered care. 
PICOT Clinical Question 
At a Cardiac Neurodevelopmental clinic in the patient population ages 5-18 years old, 
does administering the Peds QL Cardiac Module 3.0 improve education and support for 
treatment anxiety in a 6-month period? 
Nursing Theory and EBP Model 
For this project, Virginia Henderson’s Nursing Need Theory applies comprehensively.  
This nursing theory emphasizes the significance of supporting the patient to their utmost health 
and independence (Ahtisham & Jacoline, 2015).  Fourteen vital activities were composed for the 
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nurse to help carry out, all based on basic human needs.  Henderson’s approach is holistic and 
includes components such as physiological, psychological, spiritual, and social (“Henderson’s 
Nursing Need,” 2019).  The ultimate goal utilizing these nursing activities is to help the person 
reach their full independence.  This theory fits well with this project because it encourages nurses 
to promote health and illness prevention.  Giving patients and families the tools to manage 
treatment anxiety applies the essential components of communicating with others in expressing 
emotions, needs, fears or opinions.  As a Pediatric Nurse Practitioner, assisting patients with their 
growth and eventual functional independence in their own healthcare is the core of meeting the 
patient’s needs for this Need Theory. 
The Stetler Model of Evidence-Based Practice served as the framework for the 
implementation of EBP into this project.  Advanced Practice RNs (APRNs) utilize this model 
when creating new protocols and in innovative nursing led programs that originate from research 
and the most up to date practice evidence (Melnyk & Fineout-Overholt, 2015).  The Stetler 
Model is frequently employed in advancing current practices and interventions to improve 
patient outcomes in many settings such as primary care clinics.  The five steps of this model are 
both straightforward and user friendly for a wide range of clinical uses.  These steps outlined as 
Preparation, Validation, Comparative Evaluation or decision making, Translation or application, 
and Evaluation.  The Stetler Model optimized this project through the use of its key features of 
simplicity and practitioner focus.  The most current evidence of treatment anxiety screening and 
education was collected and validated through the literature review.   
Project Implementation 
This project to screen and educate both patients and families on treatment anxiety 
administered the Peds QL Cardiac Module 3.0 to patients from 5 to 18 years old.  These 
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recruited patients had pre-existing appointments at the Cardiac Neurodevelopmental (ND) Clinic 
(in person or via Telehealth) with its Nurse Practitioner.  This questionnaire is valid and reliable 
for this patient population.  After a stakeholder meeting, which had representatives from the 
Cardiology Clinic, Research Team, and the Heart Center at the pediatric hospital, there was 
collective support from management and staff for project implementation.  The intervention 
consisted of formalized treatment anxiety education and handout during the Cardiac ND 
appointment or on a follow-up phone call to the family after screening for treatment anxiety.  
Patient education included a 3-5 minute discussion with an informative handout on treatment 
anxiety, coping mechanisms, and resources for the patient and family.  Once the education was 
complete, the parents answered the same questions from the Peds QL Cardiac Module 3.0 after 
any following medical appointment to trend the treatment anxiety scores pre- and post-education.  
The project’s focus is on the treatment anxiety scores of the Peds QL Cardiac Module 3.0.  All 
patients received education and supportive materials on treatment anxiety following completion 
of the Peds QL Cardiac Module 3.0. 
The primary outcome measures are the treatment anxiety scores.  Secondary outcome 
measures include patient and parent satisfaction and HRQOL.  There were minimal costs 
associated with this project.  There was no additional staff education necessary beyond the 
clinic’s sole Nurse Practitioner, and the other financial cost was for printing family handouts.  At 
the project’s finish, a stakeholder presentation with the same members was held; this meeting 
discussed the positive effects of treatment anxiety education in pediatric cardiac patients.  This 
education session covered the problem of anxiety in this population, benefits of managing 
treatment anxiety, and family feedback on feeling heard and having open discussions on this 
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topic.  This education is cost effective due to reduction in anxiety and improved long term 
neurodevelopmental outcomes for this patient population. 
This evidenced based project received IRB approval from the UCSD Human Research 
Protections Program on December 7th, 2020.  IRB approval through the USD Hahn School of 
Nursing for this EBP Project was obtained on December 11, 2020.  Once approved, patients were 
retroactively recruited from an 8-month period and their Treatment Anxiety scores were accessed 
through EPIC patient charts.  The first set of scores was predominantly taken from patient charts.  
The follow-up period for education, additional appointments and second administration of the 
scoring was completed over a 3-month period (Dec 2020-Feb 2021).  During the follow-up 
period, a qualitative parental assessment on their feelings of satisfaction and sense of control in 
care was done as well.  Data analysis and evaluation of this project will be discussed in the 
following section. 
Evaluation Plan 
Evaluating the outcomes from this project’s intervention is one of the utmost important 
steps.  There were 7 patients enrolled in this project, with 4 females and 3 males.  The ages 
ranged from 5-17 years old with an average age of 9.  See Figures 1 and 2 for results and patient 
scores.  Overall, the scores from the questions pulled from the Treatment Anxiety section of the 
Peds QL Cardiac Module 3.0 increased after providing education.  The average score from 
before the appointment was 57.14; after the project intervention, the average score increased to 
68.75.  Of all the participants, all but one score increased after age-appropriate patient education 
was administered.  Although this project was completed on a small scale, these results are 
promising that this intervention makes a meaningful difference almost immediately for these 
patients during their healthcare related appointments. 
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Figure 1 
Pre & Post Treatment Anxiety Education Average Scores 
 
Figure 2 
Individual Pre & Post Treatment Anxiety Education Scores 
 
Another outcome that was followed was parent satisfaction.  This secondary outcome 
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feelings of being heard, gratitude for being given the opportunity to talk about this undervalued 
topic, and confidence for future appointments based on techniques and resources they learned 
about through the education intervention.  Family satisfaction during visits with providers is an 
important metric measured frequently in outpatient clinics.  This project shows that treatment 
anxiety is a topic patients and families do value having a discussion about, and it can only 
improve satisfaction scores. 
Because the patient education is already formalized in a handout and the Peds QL 
Cardiac Module 3.0 is integrated into the patient intake forms, this intervention will be relatively 
simple to continue moving forward in this clinic.  The intervention was easy to implement and 
management support was not difficult to obtain at the start of the project.  Once IRB approval 
was granted, the project was executed quickly.  No major modifications to the intervention are 
necessary to reimplement in a new cycle for another round of larger data collection.  A possible 
barrier to continued implementation can be provider time during the patient visit.  Although this 
education only takes 3-5 minutes, it can be overlooked at the end of the appointment.  
Additionally, these CHD patients are very complex and there may not be time during the visit to 
properly teach about Treatment Anxiety.  Another barrier could be no shows; during the Covid-
19 pandemic, many patients have not shown up to appointments or continually push back and 
reschedule their annual ND visit. 
Cost Benefit Analysis 
The annual cost of pediatric anxiety disorder in the United States in the school age 
population is $6405 (Pella et al., 2020).  This cost includes direct and indirect factors such as 
mental health services utilized, counseling, children’s missed school and parents’ missed work 
(Pella et al., 2020).  Additionally, the higher average costs were correlated with greater child 
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anxiety and depression severity (Pella et al., 2020).  Analysis of mental health illness financial 
costs only further demonstrates how important this issue is to screen for and treat.  The economic 
burden of anxiety among other concerns necessitates improved access to mental health services 
by promoting care in places with fewer barriers such as in primary care (Pella et al., 2020). 
The costs associated with this EBP Project include recurring costs of extra time spent 
during office visit completing the Treatment Anxiety education and funds for printing 
educational handouts for families.  Other costs and contributions in kind consist of support for 
the project from Cardiology clinic staff, managers, and providers and technology used 
(telephone, computers, EHR access).  Taken as a whole, these costs to carry out the project are 
minimal.  There is significant cost avoidance for patients that have appropriately managed 
anxiety.  Depending on severity of illness, there can be a cost-savings of up to $6405 per child 
annually.  This project improved the treatment anxiety of 6 children in a 6-month period.  The 
cost savings of 6 children per annum is $38,430.  For every dollar spent for this project, there is a 
potential $294.03 cost savings.   
Additional positive consequences include reduced risk for co-morbid conditions such as 
concurrent depression, weight gain, or acquired cognitive deficits.  Another advantage is 
improved service to patients and families with implementation of focused education during 
appointments.  This also leads to increased satisfaction from providers due to connecting with 
patients and families during visits as well as improved provider communication with patients and 
families.  A last intangible benefit lies in appreciation from both patients and families for 
relevant information and optimal care. 
Implications for Clinical Practice 
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Implementing age-appropriate education on treatment anxiety and coping mechanisms 
during ND visits is both feasible and cost-saving.  An increase in HRQOL scores improves short- 
and long-term outcomes for mental health in congenital cardiac patients.  Family satisfaction 
with the pediatric clinic increases due to feeling heard and addressing unrecognized needs.  A 
future opportunity for this project is for the patient education to be translated into Spanish and 
other languages to reach a wider patient population.  In Southern California there is a large 
Spanish speaking population.  There are multiple ways to further this initial project moving 
forward in Neurodevelopmental Clinics.  Overall, proactive steps to identify, screen, and manage 
treatment anxiety in children with CHD leads to better outcomes for both the patient and family. 
Conclusion 
Increasing amounts of research show that mental health issues, including treatment 
anxiety, for pediatric CHD patients are a growing problem in the United States.  With Congenital 
Heart Defects being the number one birth defect, there will be no shortage of future patients in 
the coming years.  As much advancement in mortality outcomes as the medical field has had, it 
is time to focus on the HRQOL outcomes for these aging children.  This project demonstrates 
that with properly implemented interventions, treatment anxiety can be reduced in the pediatric 
CHD population. 
This project is a simple, yet effective demonstration that proper education can positively 
influence pediatric patient outcomes. Focusing on mental health and long-term outcomes for 
patients with CHD is significant and achievable during annual ND appointments.  Instituting a 
standard protocol that includes the Peds QL Cardiac Module 3.0 and formal education during 
routine outpatient follow-ups could greatly benefit these patients.  This intervention could easily 
be done in any Cardiac Neurodevelopmental Clinic or Cardiology office.  Benefits of reducing 
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treatment anxiety and discussing mental health problems include improved overall health, 
decreased rates of anxiety and depression, and improved school performance.  More research on 
this topic is needed for longer term outcomes with these interventions. 
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Appendix A 
Treatment Anxiety Education Flyer 
 
